BioSpace News Archive

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare®, received an order valued at approximately $3 million to provide patient monitoring solutions and related accessories to a Midwestern U.S. based hospital.

New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly 3 million doses

DICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, announced the pricing of its upsized initial public offering of 12,000,000 shares of its common stock at a public offering price of $17.00 per share.

Avalo Therapeutics, Inc. announced that it has entered into an underwriting agreement with Jefferies LLC and RBC Capital Markets, LLC under which the underwriters agreed to purchase, on a firm commitment basis, 12,500,000 shares of common stock of the Company, at a public offering price of $2.20 per share.

Calliditas Therapeutics AB (publ) (“Calliditas” or the “Company”) (Nasdaq Stockholm: CALTX) (Nasdaq – CALT), today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its New Drug Application (NDA) seeking accelerated approval for Nefecon to December 15, 2021.

Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced the pricing of its upsized initial public offering of 10,800,000 shares of common stock at an initial public offering price of $16.00 per share

Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina Gastric Emptying Breath Test (GEBT) to now include “at home” administration under virtual supervision of Cairn Diagnostics.

Biotricity Inc. today announced that it has developed a personal medical device kit, Biokit, a bundled home-use set comprised of a digital thermometer, a pulse oximeter, and a blood pressure cuff.

Citius Pharmaceuticals, Inc. today announced that it will be joining Benzinga’s All Access Show for a 20-minute interview on Friday, September 17, 2021 at 10:10 am ET.

Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at the Clinical Trials in Rare Diseases Conference on September 14th, 2021.